Literature DB >> 9461647

Two new isoflavones from Ceiba pentandra and their effect on cyclooxygenase-catalyzed prostaglandin biosynthesis.

Y Noreen1, H el-Seedi, P Perera, L Bohlin.   

Abstract

The new isoflavone glucoside vavain 3'-O-beta-d-glucoside (1) and its aglycon, vavain (2), were isolated from the bark of Ceiba pentandra, together with the known flavan-3-ol, (+)-catechin, These novel structures were elucidated by one- and two-dimensional NMR experiments and by MS, IR, and UV spectroscopy as 5-hydroxy-7,4',5'-trimethoxyisoflavone 3'-O-beta-D-glucoside (1) and 5,3'-dihydroxy-7,4',5'-trimethoxyisoflavone (2), respectively. The compounds were isolated following bioactivity-directed fractionation, using a cyclooxygenase-1-catalyzed prostaglandin biosynthesis assay in vitro, in which compounds 1 and 2 and (+)-catechin exhibited IC50 values of 381, 97, and 80 microM, respectively (standard: indomethacin, IC50 1,1 microM). When further tested for their inhibitory effects on cyclooxygenase-2-catalyzed prostaglandin biosynthesis, 1 and 2 were found to be inactive (IC50 > 1200 and > 900 microM, respectively).

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9461647     DOI: 10.1021/np970198+

Source DB:  PubMed          Journal:  J Nat Prod        ISSN: 0163-3864            Impact factor:   4.050


  8 in total

1.  Antidiabetic effect of Ceiba pentandra extract on streptozotocin-induced non-insulin-dependent diabetic (NIDDM) rats.

Authors:  Paul Désiré D Dzeufiet; Dieudonné Y Ohandja; Léonard Tédong; Emmanuel Acha Asongalem; Théophile Dimo; Selestin D Sokeng; Pierre Kamtchouing
Journal:  Afr J Tradit Complement Altern Med       Date:  2006-08-28

2.  Evaluation of Ceiba pentandra (L.) Gaertner bark extracts for in vitro cytotoxicity on cancer cells and in vivo antitumor activity in solid and liquid tumor models.

Authors:  Ravishankar Kumar; Nitesh Kumar; Grandhi V Ramalingayya; Manganahalli Manjunath Setty; Karkala Sreedhara Rangnath Pai
Journal:  Cytotechnology       Date:  2016-07-25       Impact factor: 2.058

3.  Antioxidant activity and free radical scavenging capacity of phenolic extracts from Helicteres isora L. and Ceiba pentandra L.

Authors:  Nataraj Loganayaki; Perumal Siddhuraju; Sellamuthu Manian
Journal:  J Food Sci Technol       Date:  2011-05-05       Impact factor: 2.701

4.  Protective effect of stem bark of Ceiba pentandra linn. against paracetamol-induced hepatotoxicity in rats.

Authors:  Nirmal K Bairwa; Neeraj K Sethiya; S H Mishra
Journal:  Pharmacognosy Res       Date:  2010-01

5.  Multimodal α-Glucosidase and α-Amylase Inhibition and Antioxidant Effect of the Aqueous and Methanol Extracts from the Trunk Bark of Ceiba pentandra.

Authors:  Telesphore Benoit Nguelefack; Christian Kuete Fofie; Elvine Pami Nguelefack-Mbuyo; Adeline Kaptue Wuyt
Journal:  Biomed Res Int       Date:  2020-04-20       Impact factor: 3.411

Review 6.  Systematics, Phytochemistry, Biological Activities and Health Promoting Effects of the Plants from the Subfamily Bombacoideae (Family Malvaceae).

Authors:  Gitishree Das; Han-Seung Shin; Sanjoy Singh Ningthoujam; Anupam Das Talukdar; Hrishikesh Upadhyaya; Rosa Tundis; Swagat Kumar Das; Jayanta Kumar Patra
Journal:  Plants (Basel)       Date:  2021-03-29

Review 7.  Discovery and resupply of pharmacologically active plant-derived natural products: A review.

Authors:  Atanas G Atanasov; Birgit Waltenberger; Eva-Maria Pferschy-Wenzig; Thomas Linder; Christoph Wawrosch; Pavel Uhrin; Veronika Temml; Limei Wang; Stefan Schwaiger; Elke H Heiss; Judith M Rollinger; Daniela Schuster; Johannes M Breuss; Valery Bochkov; Marko D Mihovilovic; Brigitte Kopp; Rudolf Bauer; Verena M Dirsch; Hermann Stuppner
Journal:  Biotechnol Adv       Date:  2015-08-15       Impact factor: 14.227

8.  Hypoglycemic Properties of the Aqueous Extract from the Stem Bark of Ceiba pentandra in Dexamethasone-Induced Insulin Resistant Rats.

Authors:  Christian Kuété Fofié; Elvine Pami Nguelefack-Mbuyo; Nole Tsabang; Albert Kamanyi; Télesphore Benoît Nguelefack
Journal:  Evid Based Complement Alternat Med       Date:  2018-09-16       Impact factor: 2.629

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.